Health Care & Life Sciences » Pharmaceuticals | Pacira Pharmaceuticals Inc.

Pacira Pharmaceuticals Inc.

Pacira Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
40.96 M
Public Float
39.52 M
Pacira Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.17
Market Cap
$1.79 B
Shares Outstanding
41.3 M
Public Float
39.78 M

Profile

Address
5 Sylvan Way
Parsippany New Jersey 07054
United States
Employees -
Website http://www.pacira.com
Updated 07/08/2019
Pacira Pharmaceuticals, Inc. is a holding company, which engages in the development, commercialization, and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ.

Financials

View All

David M. Stack
Chairman, Chief Executive & Operating Officer
Mark I. Froimson
Independent Director